_id
69131621ccc777a4e85d8082
Ticker
MGX
Name
Metagenomi, Inc. Common Stock
Exchange
NASDAQ
Address
5959 Horton Street, EmeryVille, CA, United States, 94608
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://metagenomi.co
Description
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Last Close
1.62
Volume
212503
Current Price
1.79
Change
0.05
Last Updated
2026-01-05T10:27:28.337Z
Image
data:image/webp;base64,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
Ipo Date
2024-02-09T00:00:00.000Z
Market Cap
62703076
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9963333333333333
Sentiment Sources
3
Rating
4.4286
Target Price
9.3333
Strong Buy
4
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8659000
Cost Of Revenue
1324000
Gross Profit
7335000
Operating Expenses
30174000
Operating Income
-22839000
Interest Expense
-
Pretax Income
-20627000
Net Income
-20393000
Eps
-0.5460053774822756
Dividends Per Share
-
Shares Outstanding
37546751
Income Tax Expense
-234000
EBITDA
-19303000
Operating Margin
-263.7602494514378
Total Other Income Expense Net
2212000
Cash
32773000
Short Term Investments
151341000
Receivables
960000
Inventories
-
Total Current Assets
189820000
Property Plant Equipment
49906000
Total Assets
247937000
Payables
1215000
Short Term Debt
5571000
Long Term Debt
-
Total Liabilities
69490000
Equity
178447000
Bs_currency_symbol
USD
Depreciation
1324000
Change In Working Capital
-5636000
Cash From Operations
-21253000
Capital Expenditures
74000
Cash From Investing
27363000
Cash From Financing
-187000
Net Change In Cash
5923000
Cf_currency_symbol
USD
PE
-
PB
0.37465193424378107
ROE
-11.42804306040449
ROA
-8.225073304912135
FCF
-21327000
Fcf Percent
-2.4629864880471186
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
6.5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8659000
Quarters > 0 > income Statement > cost Of Revenue
1324000
Quarters > 0 > income Statement > gross Profit
7335000
Quarters > 0 > income Statement > operating Expenses
30174000
Quarters > 0 > income Statement > operating Income
-22839000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-20627000
Quarters > 0 > income Statement > net Income
-20393000
Quarters > 0 > income Statement > eps
-0.5460053774822756
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
37349449
Quarters > 0 > income Statement > income Tax Expense
-234000
Quarters > 0 > income Statement > EBITDA
-19303000
Quarters > 0 > income Statement > operating Margin
-263.7602494514378
Quarters > 0 > income Statement > total Other Income Expense Net
2212000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
32773000
Quarters > 0 > balance Sheet > short Term Investments
151341000
Quarters > 0 > balance Sheet > receivables
960000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
189820000
Quarters > 0 > balance Sheet > property Plant Equipment
49906000
Quarters > 0 > balance Sheet > total Assets
247937000
Quarters > 0 > balance Sheet > payables
1215000
Quarters > 0 > balance Sheet > short Term Debt
5571000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
69490000
Quarters > 0 > balance Sheet > equity
178447000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-20393000
Quarters > 0 > cash Flow > depreciation
1324000
Quarters > 0 > cash Flow > change In Working Capital
-5636000
Quarters > 0 > cash Flow > cash From Operations
-21253000
Quarters > 0 > cash Flow > capital Expenditures
74000
Quarters > 0 > cash Flow > cash From Investing
27363000
Quarters > 0 > cash Flow > cash From Financing
-187000
Quarters > 0 > cash Flow > net Change In Cash
5923000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.5460053774822756
Quarters > 0 > ratios > PB
0.37465193424378107
Quarters > 0 > ratios > ROE
-11.42804306040449
Quarters > 0 > ratios > ROA
-8.225073304912135
Quarters > 0 > ratios > FCF
-21327000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-2.4629864880471186
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
8513000
Quarters > 1 > income Statement > cost Of Revenue
22507000
Quarters > 1 > income Statement > gross Profit
-13994000
Quarters > 1 > income Statement > operating Expenses
6993000
Quarters > 1 > income Statement > operating Income
-20987000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-19864000
Quarters > 1 > income Statement > net Income
-19908000
Quarters > 1 > income Statement > eps
-0.5357809094221573
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
37156979
Quarters > 1 > income Statement > income Tax Expense
44000
Quarters > 1 > income Statement > EBITDA
-19652000
Quarters > 1 > income Statement > operating Margin
-246.52883824738635
Quarters > 1 > income Statement > total Other Income Expense Net
1123000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
26850000
Quarters > 1 > balance Sheet > short Term Investments
178143000
Quarters > 1 > balance Sheet > receivables
873000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
211681000
Quarters > 1 > balance Sheet > property Plant Equipment
52396000
Quarters > 1 > balance Sheet > total Assets
272284000
Quarters > 1 > balance Sheet > payables
2891000
Quarters > 1 > balance Sheet > short Term Debt
5508000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
76453000
Quarters > 1 > balance Sheet > equity
195831000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-19908000
Quarters > 1 > cash Flow > depreciation
1335000
Quarters > 1 > cash Flow > change In Working Capital
-7935000
Quarters > 1 > cash Flow > cash From Operations
-21251000
Quarters > 1 > cash Flow > capital Expenditures
127000
Quarters > 1 > cash Flow > cash From Investing
19072000
Quarters > 1 > cash Flow > cash From Financing
-166000
Quarters > 1 > cash Flow > net Change In Cash
-2345000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5357809094221573
Quarters > 1 > ratios > PB
0.3396346462511043
Quarters > 1 > ratios > ROE
-10.16590835975918
Quarters > 1 > ratios > ROA
-7.311483598007962
Quarters > 1 > ratios > FCF
-21378000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-2.5112181369669915
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
4127000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
4127000
Quarters > 2 > income Statement > operating Expenses
31947000
Quarters > 2 > income Statement > operating Income
-27820000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-24941000
Quarters > 2 > income Statement > net Income
-25039000
Quarters > 2 > income Statement > eps
-0.6763819049052802
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
37019027
Quarters > 2 > income Statement > income Tax Expense
98000
Quarters > 2 > income Statement > EBITDA
-26462000
Quarters > 2 > income Statement > operating Margin
-674.0974073176641
Quarters > 2 > income Statement > total Other Income Expense Net
2879000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
29195000
Quarters > 2 > balance Sheet > short Term Investments
196775000
Quarters > 2 > balance Sheet > receivables
1012000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
233195000
Quarters > 2 > balance Sheet > property Plant Equipment
55195000
Quarters > 2 > balance Sheet > total Assets
297866000
Quarters > 2 > balance Sheet > payables
2670000
Quarters > 2 > balance Sheet > short Term Debt
5603000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
85208000
Quarters > 2 > balance Sheet > equity
212658000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-25039000
Quarters > 2 > cash Flow > depreciation
1358000
Quarters > 2 > cash Flow > change In Working Capital
-2278000
Quarters > 2 > cash Flow > cash From Operations
-22842000
Quarters > 2 > cash Flow > capital Expenditures
288000
Quarters > 2 > cash Flow > cash From Investing
24728000
Quarters > 2 > cash Flow > cash From Financing
-77000
Quarters > 2 > cash Flow > net Change In Cash
1809000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.6763819049052802
Quarters > 2 > ratios > PB
0.3115991795747162
Quarters > 2 > ratios > ROE
-11.774304281992682
Quarters > 2 > ratios > ROA
-8.406128930458664
Quarters > 2 > ratios > FCF
-23130000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-5.604555367094742
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
9614000
Quarters > 3 > income Statement > cost Of Revenue
1461000
Quarters > 3 > income Statement > gross Profit
9614000
Quarters > 3 > income Statement > operating Expenses
30237000
Quarters > 3 > income Statement > operating Income
-20623000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-24606000
Quarters > 3 > income Statement > net Income
-23398000
Quarters > 3 > income Statement > eps
-0.6308032456253156
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
37092390
Quarters > 3 > income Statement > income Tax Expense
-1208000
Quarters > 3 > income Statement > EBITDA
-19162000
Quarters > 3 > income Statement > operating Margin
-214.5100894528812
Quarters > 3 > income Statement > total Other Income Expense Net
-3983000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
27386000
Quarters > 3 > balance Sheet > short Term Investments
220921000
Quarters > 3 > balance Sheet > receivables
1257000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
257960000
Quarters > 3 > balance Sheet > property Plant Equipment
57657000
Quarters > 3 > balance Sheet > total Assets
324599000
Quarters > 3 > balance Sheet > payables
533000
Quarters > 3 > balance Sheet > short Term Debt
5592000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
89742000
Quarters > 3 > balance Sheet > equity
234857000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-23398000
Quarters > 3 > cash Flow > depreciation
1461000
Quarters > 3 > cash Flow > change In Working Capital
-15456000
Quarters > 3 > cash Flow > cash From Operations
-26276000
Quarters > 3 > cash Flow > capital Expenditures
334000
Quarters > 3 > cash Flow > cash From Investing
28545000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
2269000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.6308032456253156
Quarters > 3 > ratios > PB
0.2827055531663949
Quarters > 3 > ratios > ROE
-9.962658128137548
Quarters > 3 > ratios > ROA
-7.208278522114979
Quarters > 3 > ratios > FCF
-26610000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-2.7678385687539007
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-09-30
Annuals > 0 > income Statement > revenue
52295000
Annuals > 0 > income Statement > cost Of Revenue
5407000
Annuals > 0 > income Statement > gross Profit
52295000
Annuals > 0 > income Statement > operating Expenses
141196000
Annuals > 0 > income Statement > operating Income
-88901000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-83571000
Annuals > 0 > income Statement > net Income
-78058000
Annuals > 0 > income Statement > eps
-2.086082087268667
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
37418470
Annuals > 0 > income Statement > income Tax Expense
-5513000
Annuals > 0 > income Statement > EBITDA
-83494000
Annuals > 0 > income Statement > operating Margin
-169.99904388564872
Annuals > 0 > income Statement > total Other Income Expense Net
5330000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
27386000
Annuals > 0 > balance Sheet > short Term Investments
220921000
Annuals > 0 > balance Sheet > receivables
1257000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
257960000
Annuals > 0 > balance Sheet > property Plant Equipment
57657000
Annuals > 0 > balance Sheet > total Assets
324599000
Annuals > 0 > balance Sheet > payables
533000
Annuals > 0 > balance Sheet > short Term Debt
5592000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
89742000
Annuals > 0 > balance Sheet > equity
234857000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-78058000
Annuals > 0 > cash Flow > depreciation
5407000
Annuals > 0 > cash Flow > change In Working Capital
-59668000
Annuals > 0 > cash Flow > cash From Operations
-109073000
Annuals > 0 > cash Flow > capital Expenditures
3114000
Annuals > 0 > cash Flow > cash From Investing
-88157000
Annuals > 0 > cash Flow > cash From Financing
84013000
Annuals > 0 > cash Flow > net Change In Cash
-113217000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.086082087268667
Annuals > 0 > ratios > PB
0.2660718858709768
Annuals > 0 > ratios > ROE
-33.236394912648976
Annuals > 0 > ratios > ROA
-24.04751709031759
Annuals > 0 > ratios > FCF
-112187000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.1452720145329383
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-09-30
Annuals > 1 > income Statement > revenue
44756000
Annuals > 1 > income Statement > cost Of Revenue
94403000
Annuals > 1 > income Statement > gross Profit
-49647000
Annuals > 1 > income Statement > operating Expenses
28845000
Annuals > 1 > income Statement > operating Income
-78492000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-60228000
Annuals > 1 > income Statement > net Income
-68255000
Annuals > 1 > income Statement > eps
-1.8214763199672206
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
37472351
Annuals > 1 > income Statement > income Tax Expense
8026999
Annuals > 1 > income Statement > EBITDA
-74285000
Annuals > 1 > income Statement > operating Margin
-175.37760300294934
Annuals > 1 > income Statement > total Other Income Expense Net
18264000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
140603000
Annuals > 1 > balance Sheet > short Term Investments
130579000
Annuals > 1 > balance Sheet > receivables
2451000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
278273000
Annuals > 1 > balance Sheet > property Plant Equipment
65153000
Annuals > 1 > balance Sheet > total Assets
364842000
Annuals > 1 > balance Sheet > payables
1791000
Annuals > 1 > balance Sheet > short Term Debt
3427000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
149668000
Annuals > 1 > balance Sheet > equity
215174000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-68255000
Annuals > 1 > cash Flow > depreciation
4207000
Annuals > 1 > cash Flow > change In Working Capital
-26429000
Annuals > 1 > cash Flow > cash From Operations
-91409000
Annuals > 1 > cash Flow > capital Expenditures
9814000
Annuals > 1 > cash Flow > cash From Investing
45734000
Annuals > 1 > cash Flow > cash From Financing
1012000
Annuals > 1 > cash Flow > net Change In Cash
-44663000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.8214763199672206
Annuals > 1 > ratios > PB
0.2908289392305762
Annuals > 1 > ratios > ROE
-31.720839878423973
Annuals > 1 > ratios > ROA
-18.708098300086064
Annuals > 1 > ratios > FCF
-101223000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2.2616632406828137
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-09-30
Annuals > 2 > income Statement > revenue
17200000
Annuals > 2 > income Statement > cost Of Revenue
1733000
Annuals > 2 > income Statement > gross Profit
15467000
Annuals > 2 > income Statement > operating Expenses
60107000
Annuals > 2 > income Statement > operating Income
-44640000
Annuals > 2 > income Statement > interest Expense
98000
Annuals > 2 > income Statement > pretax Income
-41024000
Annuals > 2 > income Statement > net Income
-43593000
Annuals > 2 > income Statement > eps
-1.163337736668831
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
37472351
Annuals > 2 > income Statement > income Tax Expense
2569000
Annuals > 2 > income Statement > EBITDA
-39193000
Annuals > 2 > income Statement > operating Margin
-259.5348837209302
Annuals > 2 > income Statement > total Other Income Expense Net
3616000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
184441000
Annuals > 2 > balance Sheet > short Term Investments
177690000
Annuals > 2 > balance Sheet > receivables
1274000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
366899000
Annuals > 2 > balance Sheet > property Plant Equipment
33258000
Annuals > 2 > balance Sheet > total Assets
414486000
Annuals > 2 > balance Sheet > payables
2011000
Annuals > 2 > balance Sheet > short Term Debt
1515000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
488914000
Annuals > 2 > balance Sheet > equity
-74428000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-43593000
Annuals > 2 > cash Flow > depreciation
1733000
Annuals > 2 > cash Flow > change In Working Capital
69487000
Annuals > 2 > cash Flow > cash From Operations
29724000
Annuals > 2 > cash Flow > capital Expenditures
13977000
Annuals > 2 > cash Flow > cash From Investing
-122200000
Annuals > 2 > cash Flow > cash From Financing
239594000
Annuals > 2 > cash Flow > net Change In Cash
147118000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.163337736668831
Annuals > 2 > ratios > PB
-0.8407968260600849
Annuals > 2 > ratios > ROE
58.5706991992261
Annuals > 2 > ratios > ROA
-10.517363674527004
Annuals > 2 > ratios > FCF
15747000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.9155232558139534
Annuals > 2 > health Score
50
Annuals > 3 > quarter
2021-09-30
Annuals > 3 > income Statement > revenue
243000
Annuals > 3 > income Statement > cost Of Revenue
387000
Annuals > 3 > income Statement > gross Profit
-144000
Annuals > 3 > income Statement > operating Expenses
23803000
Annuals > 3 > income Statement > operating Income
-23947000
Annuals > 3 > income Statement > interest Expense
302000
Annuals > 3 > income Statement > pretax Income
-21442000
Annuals > 3 > income Statement > net Income
-21442000
Annuals > 3 > income Statement > eps
-3.6160577112152428
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5929662
Annuals > 3 > income Statement > income Tax Expense
306000
Annuals > 3 > income Statement > EBITDA
-20753000
Annuals > 3 > income Statement > operating Margin
-9854.732510288066
Annuals > 3 > income Statement > total Other Income Expense Net
2505000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
39296000
Annuals > 3 > balance Sheet > short Term Investments
68858000
Annuals > 3 > balance Sheet > receivables
490000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
108916000
Annuals > 3 > balance Sheet > property Plant Equipment
22140000
Annuals > 3 > balance Sheet > total Assets
141992000
Annuals > 3 > balance Sheet > payables
1354000
Annuals > 3 > balance Sheet > short Term Debt
687000
Annuals > 3 > balance Sheet > long Term Debt
30276000
Annuals > 3 > balance Sheet > total Liabilities
174536000
Annuals > 3 > balance Sheet > equity
-32544000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-21442000
Annuals > 3 > cash Flow > depreciation
387000
Annuals > 3 > cash Flow > change In Working Capital
46255000
Annuals > 3 > cash Flow > cash From Operations
24257000
Annuals > 3 > cash Flow > capital Expenditures
2903000
Annuals > 3 > cash Flow > cash From Investing
-74316000
Annuals > 3 > cash Flow > cash From Financing
39922000
Annuals > 3 > cash Flow > net Change In Cash
-10137000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-3.6160577112152428
Annuals > 3 > ratios > PB
-0.30428145095870207
Annuals > 3 > ratios > ROE
65.88618485742379
Annuals > 3 > ratios > ROA
-15.10085075215505
Annuals > 3 > ratios > FCF
21354000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
87.87654320987654
Annuals > 3 > health Score
50
Valuation > metrics > PE
-0.5460053774822756
Valuation > metrics > PB
0.37465193424378107
Valuation > final Score
70
Valuation > verdict
62.5% Undervalued
Profitability > metrics > ROE
-11.42804306040449
Profitability > metrics > ROA
-10.74333579180276
Profitability > metrics > Net Margin
-2.355121838549486
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.38941534461212574
Risk > metrics > Interest Coverage
-17.25
Risk > final Score
-9
Risk > verdict
High
Liquidity > metrics > Current Ratio
27.972295903330387
Liquidity > metrics > Quick Ratio
27.972295903330387
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-336
Prev Risks > 1
-13
Prev Risks > 2
45
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:12:11.004Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-11
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.55
Earnings History > 0 > eps Estimate
-0.8
Earnings History > 0 > eps Difference
0.25
Earnings History > 0 > surprise Percent
31.25
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.54
Earnings History > 1 > eps Estimate
-0.72
Earnings History > 1 > eps Difference
0.18
Earnings History > 1 > surprise Percent
25
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.68
Earnings History > 2 > eps Estimate
-0.75
Earnings History > 2 > eps Difference
0.07
Earnings History > 2 > surprise Percent
9.3333
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-17
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.37
Earnings History > 3 > eps Estimate
-0.77
Earnings History > 3 > eps Difference
0.4
Earnings History > 3 > surprise Percent
51.9481
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.51
Earnings History > 4 > eps Estimate
-0.75
Earnings History > 4 > eps Difference
0.24
Earnings History > 4 > surprise Percent
32
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-15
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.29
Earnings History > 5 > eps Estimate
-0.7
Earnings History > 5 > eps Difference
0.41
Earnings History > 5 > surprise Percent
58.5714
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.19
Earnings History > 6 > eps Estimate
-0.78
Earnings History > 6 > eps Difference
-0.41
Earnings History > 6 > surprise Percent
-52.5641
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.5149
Earnings History > 7 > eps Estimate
-2.04
Earnings History > 7 > eps Difference
1.5251
Earnings History > 7 > surprise Percent
74.7598
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMetagenomi (NASDAQ:MGX) and UCB (OTCMKTS:UCBJY) Critical Survey Defense World
Read more →Primate study moves hemophilia A gene treatment toward 2027 human test Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$9.3333
Analyst Picks
Strong Buy
4
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Metagenomi, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.55
EPS Estimate
-0.8
EPS Difference
0.25
Surprise Percent
31.25%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.